Biomarker-guided Sequencing

Biomarker-Guided Sequencing is a treatment strategy in immuno-oncology that uses specific molecular or cellular biomarkers to determine the optimal order of therapeutic interventions based on their predictive value for patient response.

14

Publications

2.1K

Citations

233

Authors

81

Institutions

Publications per year

2017–2026

11

Authors

233

  1. JH
    Jong Ho Cho

    Samsung Medical Center, South Korea

    1 publications · 20 citations

    1

    h-index

  2. KW
    Kenneth W. Kinzler

    Johns Hopkins University, United States

    1 publications · 517 citations

    1

    h-index

  3. KJ
    Kenneth J. Pienta

    University of Michigan, United States

    1 publications · 637 citations

    1

    h-index

  4. HY
    Ho Yeong Lim

    Samsung Medical Center, South Korea

    1 publications · 20 citations

    1

    h-index

  5. GN
    Gurudatta Naik

    Institute for Health Metrics and Evaluation, United States

    1 publications · 101 citations

    1

    h-index

1–5 of 233

Venues

  1. Science Translational Medicine

    STM · 2 publications · 1.2K citations

    2

    h-index

  2. The Oncologist

    2 publications · 126 citations

    2

    h-index

  3. Cancer Discovery

    1 publications · 477 citations

    1

    h-index

  4. Methods

    1 publications · 66 citations

    1

    h-index

  5. Cancer

    1 publications · 101 citations

    1

    h-index

1–5